Clinical trials
Gastrointestinal Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
107 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 7 |
| 2017 | 9 |
| 2018 | 10 |
| 2019 | 11 |
| 2020 | 8 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 107 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Royal Marsden NHS Foundation Trust | 5 |
| First Affiliated Hospital Xi'an Jiaotong University | 3 |
| Peking University | 3 |
| Peking University Cancer Hospital & Institute | 3 |
| Xiaonan Cui | 3 |
| Ain Shams University | 2 |
| Curegenix Inc. | 2 |
| Fudan University | 2 |
| Radboud University Medical Center | 2 |
| Shandong University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Neoplasms | 107 |
| Colorectal Neoplasms | 23 |
| Neoplasms | 20 |
| Stomach Neoplasms | 16 |
| Gastrointestinal Diseases | 13 |
| Digestive System Neoplasms | 12 |
| Breast Neoplasms | 10 |
| Digestive System Diseases | 10 |
| Head and Neck Neoplasms | 9 |
| Intestinal Neoplasms | 8 |
Trials
Showing 51 to 75 of 107. Each trial links to its page on Pharma Observatory.
7 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.